1. Kim JY, Kang K, Kang J, Koo J, Kim DH, Kim BJ, et al. Executive summary of Stroke Statistics in Korea 2018: a report from the Epidemiology Research Council of the Korean Stroke Society. J Stroke. 2019; 21:42–59.
2. Rost NS, Brodtmann A, Pase MP, van Veluw SJ, Biffi A, Duering M, et al. Post-stroke cognitive impairment and dementia. Circ Res. 2022; 130:1252–71.
3. Jaillard A, Naegele B, Trabucco-Miguel S, LeBas JF, Hommel M. Hidden dysfunctioning in subacute stroke. Stroke. 2009; 40:2473–9.
4. Rasquin SM, Lodder J, Ponds RW, Winkens I, Jolles J, Verhey FR. Cognitive functioning after stroke: a one-year follow-up study. Dement Geriatr Cogn Disord. 2004; 18:138–44.
5. Hoffmann M. Higher cortical function deficits after stroke: an analysis of 1,000 patients from a dedicated cognitive stroke registry. Neurorehabil Neural Repair. 2001; 15:113–27.
6. Leśniak M, Bak T, Czepiel W, Seniów J, Członkowska A. Frequency and prognostic value of cognitive disorders in stroke patients. Dement Geriatr Cogn Disord. 2008; 26:356–63.
7. Ballard C, Stephens S, Kenny R, Kalaria R, Tovee M, O'Brien J. Profile of neuropsychological deficits in older stroke survivors without dementia. Dement Geriatr Cogn Disord. 2003; 16:52–6.
8. Dobrow MJ, Hagens V, Chafe R, Sullivan T, Rabeneck L. Consolidated principles for screening based on a systematic review and consensus process. CMAJ. 2018; 190:E422–9.
9. Quinn TJ, Elliott E, Langhorne P. Cognitive and mood assessment tools for use in stroke. Stroke. 2018; 49:483–90.
10. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12:189–98.
11. Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005; 53:695–9. Erratum in: J Am Geriatr Soc 2019;67:1991.
12. Burton L, Tyson SF. Screening for cognitive impairment after stroke: a systematic review of psychometric properties and clinical utility. J Rehabil Med. 2015; 47:193–203.
13. Kosgallana A, Cordato D, Chan DKY, Yong J. Use of cognitive screening tools to detect cognitive impairment after an ischaemic stroke: a systematic review. SN Compr Clin Med. 2019; 1:255–62.
14. Zhang H, Zhang XN, Zhang HL, Huang L, Chi QQ, Zhang X, et al. Differences in cognitive profiles between traumatic brain injury and stroke: a comparison of the Montreal Cognitive Assessment and Mini-Mental State Examination. Chin J Traumatol. 2016; 19:271–4.
15. Demeyere N, Riddoch MJ, Slavkova ED, Bickerton WL, Humphreys GW. The Oxford Cognitive Screen (OCS): validation of a stroke-specific short cognitive screening tool. Psychol Assess. 2015; 27:883–94.
16. Moore MJ, Demeyere N. Lesion symptom mapping of domain-specific cognitive impairments using routine imaging in stroke. Neuropsychologia. 2022; 167:108159.
17. Demeyere N, Riddoch MJ, Slavkova ED, Jones K, Reckless I, Mathieson P, et al. Domain-specific versus generalized cognitive screening in acute stroke. J Neurol. 2016; 263:306–15.
18. Mancuso M, Varalta V, Sardella L, Capitani D, Zoccolotti P, Antonucci G; Italian OCS Group. Italian normative data for a stroke specific cognitive screening tool: the Oxford Cognitive Screen (OCS). Neurol Sci. 2016; 37:1713–21.
19. Kong AP, Lam PH, Ho DW, Lau JK, Humphreys GW, Riddoch J, et al. The Hong Kong version of the Oxford Cognitive Screen (HK-OCS): validation study for Cantonese-speaking chronic stroke survivors. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2016; 23:530–48.
20. Shendyapina M, Kuzmina E, Kazymaev S, Petrova A, Demeyere N, Weekes BS. The Russian version of the Oxford Cognitive Screen: validation study on stroke survivors. Neuropsychology. 2019; 33:77–92.
21. Robotham RJ, Riis JO, Demeyere N. A Danish version of the Oxford cognitive screen: a stroke-specific screening test as an alternative to the MoCA. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2020; 27:52–65.
22. Valério D, Almeida J, Demeyere N, Lima M, Nogueira J, Santana I. The European Portuguese version of the Oxford Cognitive Screening (OCS-Pt): a screening test for acute stroke patients. Neurol Sci. 2022; 43:3717–28.
23. Huygelier H, Schraepen B, Miatton M, Welkenhuyzen L, Michiels K, Note E, et al. The Dutch Oxford Cognitive Screen (OCS-NL): psychometric properties in Flemish stroke survivors. Neurol Sci. 2022; 43:6349–58.
24. Sanctuary C, Hewitt L, Demeyere N, Kankkunen K, Oxenham DV, Simpson DB, et al. The Oxford Cognitive Screen for use with Australian people after stroke (OCS-AU): the adaptation process and determining cut scores for cognitive impairment using a cross-sectional normative study. Aust Occup Ther J. 2023; 70:73–85.
25. West SG, Finch JF, Curran PJ. Structural equation models with nonnormal variables: problems and remedies. In : Hoyle RH, editor. Structural equation modeling: concepts, issues, and applications. Sage Publications;1995. p. 56–75.
26. Demeyere N. Oxford Cognitive Screen translation and linguistic validation process. Oxford University Innovation;2016.
27. Kim HS. Korean Language Use of Frequency. National Institute of Korean Language;2005.
28. Christensen KJ, Multhaup KS, Nordstrom S, Voss K. A cognitive battery for dementia: development and measurement characteristics. Psychol Assess J Consult Clin Psychol. 1991; 3:168–74.
29. Kang YW, Park JS, Yu KH, Lee BC. A reliability, validity, and normative study of the Korean-Montreal Cognitive Assessment(K-MoCA) as an instrument for screening of Vascular Cognitive Impairment(VCI). Korean J Clin Psychol. 2009; 28:549–62.
30. Lim SY, Lee EJ, Jeong SW, Kim HC, Jeong CH, Jeon TY, et al. The validation study of beck depression scale 2 in Korean version. Anxiety Mood. 2011; 7:48–53.
31. Milosevich ET, Moore MJ, Pendlebury ST, Demeyere N. Domain-specific cognitive impairment 6 months after stroke: the value of early cognitive screening. Int J Strok. 2023. doi: 10.1177/17474930231205787 [Epub ahead of print].